Expansion in global markets, backward integration, and therapeutic focus drive earnings momentum across quarters Supriya Lifescience Ltd., a global leader in active pharmaceutical ingredients (APIs), has reported its highest-ever annual revenue of ₹696.48 crore in FY25, marking a 22 percent year-on-year growth over ₹570.37 crore posted in FY24. The company also recorded a 57.8 percent … Continue reading Supriya Lifescience Delivers Record FY25 Performance with 22 Percent Revenue Growth and 38 Percent Surge in Q4 PAT